132 related articles for article (PubMed ID: 34246421)
1. Incidence of contrast-induced nephropathy after a computed tomography scan.
Barrios López A; García Martínez F; Rodríguez JI; Montero-San-Martín B; Gómez Rioja R; Diez J; Martín-Hervás C
Radiologia (Engl Ed); 2021; 63(4):307-313. PubMed ID: 34246421
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting the incidence of contrast-induced nephropathy in patients undergoing computed tomography.
Heras Benito M; Garrido Blázquez M; Gómez Sanz Y; Bernardez Mardomingo M; Ruiz Cacho J; Rodríguez Recio FJ; Fernández-Reyes Luis MJ
Radiologia (Engl Ed); 2018; 60(4):326-331. PubMed ID: 29779857
[TBL] [Abstract][Full Text] [Related]
3. The administration of contrast media: is there a risk of acute kidney injury?
Ferrer Puchol MD; Montesinos García P; Forment Navarro M; Sanz Rodrigo E; Blanco Pérez E; Taberner López E
Radiologia (Engl Ed); 2019; 61(4):306-314. PubMed ID: 30910216
[TBL] [Abstract][Full Text] [Related]
4. Probability of reduced renal function after contrast-enhanced CT: a model based on serum creatinine level, patient age, and estimated glomerular filtration rate.
Herts BR; Schneider E; Obuchowski N; Poggio E; Jain A; Baker ME
AJR Am J Roentgenol; 2009 Aug; 193(2):494-500. PubMed ID: 19620448
[TBL] [Abstract][Full Text] [Related]
5. Incidence of nonconfounded post-computed tomography acute kidney injury in hospitalized patients with stable renal function receiving intravenous iodinated contrast material.
Moore A; Dickerson E; Dillman JR; Vummidi D; Kershaw DB; Khalatbari S; Davenport MS
Curr Probl Diagn Radiol; 2014; 43(5):237-41. PubMed ID: 24909428
[TBL] [Abstract][Full Text] [Related]
6. Is the risk of contrast-induced nephropathy a real contraindication to perform intravenous contrast enhanced Computed Tomography for non-traumatic acute abdomen in Emergency Surgery Department?
De Simone B; Ansaloni L; Sartelli M; Gaiani F; Leandro G; De' Angelis GL; Di Mario F; Coccolini F; Catena F
Acta Biomed; 2018 Dec; 89(9-S):158-172. PubMed ID: 30561410
[TBL] [Abstract][Full Text] [Related]
7. Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol.
Werner S; Bez C; Hinterleitner C; Horger M
PLoS One; 2020; 15(5):e0233433. PubMed ID: 32437415
[TBL] [Abstract][Full Text] [Related]
8. Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants.
Fananapazir G; Troppmann C; Corwin MT; Nikpour AM; Naderi S; Lamba R
Abdom Radiol (NY); 2016 Nov; 41(11):2182-2186. PubMed ID: 27377897
[TBL] [Abstract][Full Text] [Related]
9. Contrast-induced nephropathy after peripheral vascular intervention: Long-term renal outcome and risk factors for progressive renal dysfunction.
Al Adas Z; Lodewyk K; Robinson D; Qureshi S; Kabbani LS; Sullivan B; Shepard AD; Weaver MR; Nypaver TJ
J Vasc Surg; 2019 Mar; 69(3):913-920. PubMed ID: 30292616
[TBL] [Abstract][Full Text] [Related]
10. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
Boccalandro F; Amhad M; Smalling RW; Sdringola S
Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
[TBL] [Abstract][Full Text] [Related]
11. Incidence of CT Contrast Agent-Induced Nephropathy: Toward a More Accurate Estimation.
Garfinkle MA; Stewart S; Basi R
AJR Am J Roentgenol; 2015 Jun; 204(6):1146-51. PubMed ID: 26001222
[TBL] [Abstract][Full Text] [Related]
12. [Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial].
Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; van Ommen V; Wildberger JE
Ned Tijdschr Geneeskd; 2018; 161():D1734. PubMed ID: 29328007
[TBL] [Abstract][Full Text] [Related]
13. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
[TBL] [Abstract][Full Text] [Related]
14. Discordance between serum creatinine and creatinine clearance for identification of ED patients with abdominal pain at risk for contrast-induced nephropathy.
Band RA; Gaieski DF; Mills AM; Sease KL; Shofer FS; Robey JL; Hollander JE
Am J Emerg Med; 2007 Mar; 25(3):268-72. PubMed ID: 17349899
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.
Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; Ommen VV; Wildberger JE
Lancet; 2017 Apr; 389(10076):1312-1322. PubMed ID: 28233565
[TBL] [Abstract][Full Text] [Related]
16. Contrast-induced nephropathy (CIN) of patients with renal dysfunction in CT examination.
Fukushima Y; Miyazawa H; Nakamura J; Taketomi-Takahashi A; Suto T; Tsushima Y
Jpn J Radiol; 2017 Aug; 35(8):427-431. PubMed ID: 28528465
[TBL] [Abstract][Full Text] [Related]
17. Contrast-induced nephropathy after computed tomography.
Selistre Lda S; Souza VC; Dubourg L; Wagner MB; Hoefel Filho JR; Saitovitch D
J Bras Nefrol; 2015; 37(1):27-31. PubMed ID: 25923747
[TBL] [Abstract][Full Text] [Related]
18. Prevention of contrast-induced nephropathy with ascorbic acid.
Zhou L; Chen H
Intern Med; 2012; 51(6):531-5. PubMed ID: 22449658
[TBL] [Abstract][Full Text] [Related]
19. Use of cystatin C and serum creatinine for the diagnosis of contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography at an oncology centre.
Fortalesa Melo JI; Chojniak R; Costa Silva DH; Oliveira Junior JC; Vieira Bitencourt AG; Holanda Silva D; Guimarães MD; Silva HC; Dias DG; Rodrigues WC; Brancucci EL; Cruz BM; Schiavon BN; Argenton JL; Camporini MA; Zocchio A
PLoS One; 2015; 10(5):e0122877. PubMed ID: 25961558
[TBL] [Abstract][Full Text] [Related]
20. Contrast-induced nephropathy in patients with active cancer undergoing contrast-enhanced computed tomography.
Hong SI; Ahn S; Lee YS; Kim WY; Lim KS; Lee JH; Lee JL
Support Care Cancer; 2016 Mar; 24(3):1011-7. PubMed ID: 26238629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
